Montara Therapeutics Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1M
- Investors
-
8
Montara Therapeutics General Information
Description
Operator of a biopharmaceutical company intended to enhance the safety and efficacy of treatments for neurological diseases. The company specializes in brain-specific pharmacology by leveraging human genetics and machine learning to identify and validate drug targets, enabling medical professionals to develop therapies for previously undruggable targets and improving treatment outcomes for patients with neurological conditions.
Contact Information
Website
www.montaratx.comCorporate Office
- 135 Mississippi Street
- San Francisco, CA 94107
- United States
Corporate Office
- 135 Mississippi Street
- San Francisco, CA 94107
- United States
Montara Therapeutics Timeline
Montara Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 09-Jun-2026 | $1M | Completed | Pre-Clinical Trials | ||
| 3. Grant | 21-Mar-2025 | Completed | Pre-Clinical Trials | |||
| 2. Seed Round | 26-Feb-2025 | $20M | $28M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 19-Jan-2024 | $8M | $8M | Completed | Pre-Clinical Trials |
Montara Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-2 | ||||||||
| Seed-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Montara Therapeutics Patents
Montara Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026060039-A1 | Central nervous system-selective activity of lrrk2 inhibitors | Pending | 10-Sep-2024 | ||
| WO-2026060039-A8 | Central nervous system-selective activity of lrrk2 inhibitors | Pending | 10-Sep-2024 | ||
| WO-2026060044-A1 | Central nervous system-selective activity of lxr agonists | Pending | 10-Sep-2024 | ||
| WO-2026060044-A8 | Central nervous system-selective activity of lxr agonists | Pending | 10-Sep-2024 | ||
| WO-2026060044-A9 | Central nervous system-selective activity of lxr agonists | Pending | 10-Sep-2024 |
Montara Therapeutics Signals
Montara Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Michael J. Fox Foundation | Limited Partner | |||
| Bayshore Global Management | Family Office | Minority | ||
| BEVC (Berkeley) | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Dolby Family Ventures | Venture Capital | Minority |
Montara Therapeutics FAQs
-
When was Montara Therapeutics founded?
Montara Therapeutics was founded in 2023.
-
Where is Montara Therapeutics headquartered?
Montara Therapeutics is headquartered in San Francisco, CA.
-
What is the size of Montara Therapeutics?
Montara Therapeutics has 24 total employees.
-
What industry is Montara Therapeutics in?
Montara Therapeutics’s primary industry is Drug Discovery.
-
Is Montara Therapeutics a private or public company?
Montara Therapeutics is a Private company.
-
What is Montara Therapeutics’s current revenue?
The current revenue for Montara Therapeutics is .
-
How much funding has Montara Therapeutics raised over time?
Montara Therapeutics has raised $28M.
-
Who are Montara Therapeutics’s investors?
Michael J. Fox Foundation, Bayshore Global Management, BEVC (Berkeley), , and Dolby Family Ventures are 5 of 8 investors who have invested in Montara Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process